Total Payments
$56,209
2024 Payments
$3,692
Companies
61
Transactions
863
Medicare Patients
2,004
Medicare Billing
$355,498
Payment Breakdown by Category
Other$29,112 (51.8%)
Food & Beverage$16,242 (28.9%)
Travel$8,463 (15.1%)
Consulting$1,240 (2.2%)
Gifts$1,020 (1.8%)
Education$132.58 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,117 | 10 | 34.0% |
| Food and Beverage | $16,242 | 766 | 28.9% |
| Honoraria | $9,995 | 7 | 17.8% |
| Travel and Lodging | $8,463 | 36 | 15.1% |
| Consulting Fee | $1,240 | 1 | 2.2% |
| Gift | $1,020 | 5 | 1.8% |
| Education | $132.58 | 38 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| USWM, LLC | $31,957 | 93 | $0 (2024) |
| Crawford Healthcare Inc | $6,848 | 13 | $0 (2018) |
| US WorldMeds, LLC | $2,973 | 25 | $0 (2020) |
| ITI, Inc. | $1,665 | 65 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $1,365 | 63 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $1,172 | 41 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,135 | 47 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,063 | 55 | $0 (2024) |
| ABBVIE INC. | $861.13 | 58 | $0 (2024) |
| Indivior Inc. | $580.98 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,692 | 163 | Teva Pharmaceuticals USA, Inc. ($693.39) |
| 2023 | $4,197 | 210 | Janssen Pharmaceuticals, Inc ($633.20) |
| 2022 | $10,083 | 132 | USWM, LLC ($7,872) |
| 2021 | $25,781 | 190 | USWM, LLC ($23,862) |
| 2020 | $1,718 | 60 | US WorldMeds, LLC ($729.16) |
| 2019 | $2,760 | 55 | US WorldMeds, LLC ($2,232) |
| 2018 | $3,265 | 24 | Crawford Healthcare Inc ($2,871) |
| 2017 | $4,713 | 29 | Crawford Healthcare Inc ($3,977) |
All Payment Transactions
863 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.48 | General |
| Category: PSYCHIATRY | ||||||
| 12/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: Wound Care | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $98.10 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $14.84 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: VIROLOGY | ||||||
| 11/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: VIROLOGY | ||||||
| 11/07/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: OUD | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: PSYCHIATRY | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/29/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Neuroscience | ||||||
| 10/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Noven Therapeutics, LLC | Secuado (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: CNS Psychiatry | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 706 | 2,559 | $249,060 | $122,528 |
| 2022 | 15 | 334 | 956 | $176,833 | $76,460 |
| 2021 | 15 | 492 | 1,028 | $218,406 | $96,970 |
| 2020 | 13 | 472 | 934 | $152,200 | $59,540 |
Total Patients
2,004
Total Services
5,477
Medicare Billing
$355,498
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 44 | 180 | $45,370 | $18,802 | 41.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 85 | 477 | $28,620 | $15,951 | 55.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 79 | 356 | $26,700 | $15,142 | 56.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 75 | 445 | $20,025 | $14,550 | 72.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 177 | $36,462 | $14,419 | 39.5% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 54 | 103 | $25,750 | $12,687 | 49.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 66 | 424 | $21,200 | $11,645 | 54.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 57 | 155 | $10,075 | $5,121 | 50.8% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 12 | 69 | $11,592 | $4,900 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 35 | $4,900 | $2,098 | 42.8% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 18 | 18 | $4,716 | $2,009 | 42.6% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 23 | 25 | $6,150 | $1,716 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 14 | $3,150 | $1,670 | 53.0% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 18 | 18 | $2,250 | $963.00 | 42.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 49 | 49 | $980.00 | $597.37 | 61.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 14 | $1,120 | $256.23 | 22.9% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 55 | 349 | $87,948 | $36,514 | 41.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 167 | $34,402 | $13,548 | 39.4% |
| 99350 | Established patient home visit, typically 1 hour | Office | 2022 | 18 | 40 | $10,025 | $4,886 | 48.7% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 38 | 38 | $9,956 | $4,606 | 46.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 11 | 88 | $3,960 | $2,941 | 74.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 31 | 66 | $6,600 | $2,862 | 43.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 30 | 40 | $5,000 | $2,543 | 50.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 11 | 49 | $3,675 | $2,185 | 59.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,220 | $1,646 | 51.1% |
About Dr. Michael Miller, D.O
Dr. Michael Miller, D.O is a Hospice and Palliative Medicine healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730122268.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Miller, D.O has received a total of $56,209 in payments from pharmaceutical and medical device companies, with $3,692 received in 2024. These payments were reported across 863 transactions from 61 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,117).
As a Medicare-enrolled provider, Miller has provided services to 2,004 Medicare beneficiaries, totaling 5,477 services with total Medicare billing of $355,498. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospice and Palliative Medicine
- Other Specialties Surgery, Addiction Medicine
- Location Indianapolis, IN
- Active Since 06/13/2006
- Last Updated 09/09/2025
- Taxonomy Code 2086H0002X
- Entity Type Individual
- NPI Number 1730122268
Products in Payments
- Lucemyra (Drug) $29,167
- KerraCel Ag (Device) $6,848
- Lucemyra/Lofexidine (Drug) $2,275
- CAPLYTA (Drug) $1,966
- SYMJEPI (Drug) $1,952
- ZIMHI (Drug) $1,035
- REXULTI (Drug) $905.56
- HETLIOZ (Drug) $861.59
- Austedo XR (Drug) $729.98
- INVEGA SUSTENNA (Drug) $617.57
- SPRAVATO (Drug) $517.74
- APTIOM (Drug) $484.29
- VRAYLAR (Drug) $457.88
- Xeomin (Biological) $436.37
- Qelbree (Drug) $387.83
- MAVYRET (Drug) $358.20
- Horizant (Drug) $337.61
- SUBLOCADE (Drug) $337.10
- Zubsolv (Drug) $333.98
- AUSTEDO (Drug) $327.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospice and Palliative Medicine Doctors in Indianapolis
Lisa Landrum, Md, MD
Hospice and Palliative Medicine — Payments: $2,680
Hospice and Palliative Medicine $2,680
Dr. Hussain Rangoonwala, Md, MD
Hospice and Palliative Medicine — Payments: $211.22
Hospice and Palliative Medicine $211.22
Muhammad Jan, Md, MD
Hospice and Palliative Medicine — Payments: $156.09
Hospice and Palliative Medicine $156.09
Kari Kendall, M.d, M.D
Hospice and Palliative Medicine — Payments: $129.54
Hospice and Palliative Medicine $129.54
Deshini Moonesinghe, M.d, M.D
Hospice and Palliative Medicine — Payments: $123.33
Hospice and Palliative Medicine $123.33
Dr. Colleen Brown, Md, MD
Hospice and Palliative Medicine — Payments: $112.06
Hospice and Palliative Medicine $112.06